Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature

F. Panarelli, Joseph; Vera, Vanessa; Sheybani, Arsham; M. Radcliffe, Nathan; G. Fiscella, Richard; A. Francis, Brian; Smith, Oluwatosin; J. Noecker, Robert

doi:10.2147/opth.s390955

Public

Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature

Published in Clinical ophthalmology • Jan 1, 2023

Authors:

Joseph F. Panarelli

Vanessa Vera

Arsham Sheybani

Abstract

The Xen gel stent (Allergan Inc, an AbbVie company; Dublin, Ireland) was conceived as an option for patients requiring modest IOP reduction but for whom trabeculectomy was not yet indicated. As with any glaucoma surgery, establishing criteria for patient selection and identifying factors that contri...

Subject

Medicine

Glaucoma

Dry needling

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!